Boston Scientific Corp (BSX) insider trading
Every open-market stock purchase and sale by Boston Scientific Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Michael F Mahoney (CEO) and 3 others bought $9.5M in the last 90 days, growing their stake 13%.
- Congress: Kevin Hern sold $50K to $100K, 6 weeks ago.
Last 12 months: insiders bought $10M (8 buys) and sold $24.3M (5 sales). Last close $44.51 on Oct 21, 2026.
Recent BSX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | Kevin Hern (Representative) | Sold | $50K–100K |
| Sep 4, 2026 | Kevin Hern (Representative) | Sold | $50K–100K |
| Sep 3, 2026 | Kevin Hern (Representative) | Sold | $1K–15K |
| Sep 3, 2026 | Kevin Hern (Representative) | Sold | $1K–15K |
| Sep 3, 2026 | Kevin Hern (Representative) | Sold | $1K–15K |
| Sep 2, 2026 | Padraig Andrew O'Connor (VP) | Sold (not open market) | $27.4K |
| Sep 2, 2026 | Padraig Andrew O'Connor (VP) | Bought (not open market) | — |
| Sep 2, 2026 | Padraig Andrew O'Connor (VP) | Bought (not open market) | — |
| Aug 31, 2026 | Kevin Hern (Representative) | Sold | $15K–50K |
| Aug 25, 2026 | Susan E Morano (Director) | Bought | $100K |
| Aug 18, 2026 | Gilbert Cisneros (Representative) | Bought | $1K–15K |
| Aug 11, 2026 | Emily Woodworth (C-suite exec) | Bought (not open market) | $150K |
| Aug 10, 2026 | Jonathan Monson (CFO) | Bought (not open market) | $500K |
| Aug 5, 2026 | David C Habiger (Director) | Bought | $99.9K |
| Aug 4, 2026 | David C Habiger (Director) | Bought | $6.8K |
| Aug 3, 2026 | Michael F Mahoney (CEO) | Bought | $9M |
| Aug 3, 2026 | Michael F Mahoney (CEO) | Bought (not open market) | $1.1M |
| Aug 3, 2026 | David C Habiger (Director) | Bought | $50.1K |
| Jul 31, 2026 | Joseph Michael Fitzgerald (VP) | Bought (not open market) | $3M |
| Jul 31, 2026 | Edward J Ludwig (Director) | Bought | $227K |
| Jul 1, 2026 | Jonathan Monson (CFO) | Sold (not open market) | $43.5K |
| Jul 1, 2026 | Jonathan Monson (CFO) | Bought (not open market) | — |
| Jul 1, 2026 | Jonathan Monson (CFO) | Bought (not open market) | — |
| Jun 5, 2026 | Gilbert Cisneros (Representative) | Sold | $1K–15K |
| Jun 5, 2026 | Gilbert Cisneros (Representative) | Bought | $1K–15K |
Who's trading BSX
- Kevin Hern, Representative: sold $172K (7 sales), last Sep 9, 2026
- Padraig Andrew O'Connor, VP: other filings, last Sep 2, 2026
- Susan E Morano, Director: bought $100K (1 buy), last Aug 25, 2026
- Gilbert Cisneros, Representative: bought $64K (8 buys), sold $16K (2 sales), last Aug 18, 2026
- Emily Woodworth, C-suite exec: other filings, last Aug 11, 2026
- Jonathan Monson, CFO: other filings, last Aug 10, 2026
- David C Habiger, Director: bought $408K (5 buys), last Aug 5, 2026
- Michael F Mahoney, CEO: bought $9M (1 buy), sold $15M (2 sales), last Aug 3, 2026
- Joseph Michael Fitzgerald, VP: sold $5M (3 sales), last Jul 31, 2026
- Edward J Ludwig, Director: bought $430K (2 buys), last Jul 31, 2026
- John Boozman, Senator: sold $16K (2 sales), last Jun 4, 2026
- Cheryl Pegus, Director: bought $100K (1 buy), last May 20, 2026
- Ellen M Zane, Director: sold $2.6M (3 sales), last May 7, 2026
- Jessica L Mega, Director: other filings, last May 7, 2026
- Cathy R Smith, Director: other filings, last May 7, 2026
Get free alerts when an insider at Boston Scientific Corp files a new trade →